Photo

Photo detail

Faheem Hasnain
Chairman
Aspen Neuroscience

Stories this photo appears in:

Aspen Neuroscience Raises $147.5M in Series B Round

BIOTECH: Starting Clinical Trial for Parkinson’s Stem Cell Therapy

San Diego-based Aspen Neuroscience, Inc. announced a Series B financing round of $147.5 million on May 9 to further advance its treatment of Parkinson’s disease using autologous stem cell therapies.